Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
On January 5, 2022, Eagle Pharmaceuticals announced the launch of an AP-rated generic version of Par Pharmaceutical’s Vasostrict (vasopressin) injection on January 17, 2022.
